COVER STORY - Industry Watch - Although the concern about biological warfare has thrust vaccine-makers and biological and chemical weapons detection companies into the spotlight, industry followers think it's unlikely that the threat of bioterrorism will spur firms to seek out acquisitions in order to access biological warfare detection or prevention technology.
Year of publication:
Mergers & acquisitions. - New York, NY : Investment Dealers' Digest, ISSN 0026-0010, ZDB-ID 8628555. - Vol. 36.2001, 12, p. 20-21